Sun Pharma Advanced Research Co Quarterly Results for Trading Insights
SPARC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-76 Cr
QSept 2025
Sun Pharma Advanced Research Co Quarterly Results Key Highlights
- Revenue of ₹8 Cr in Sept 2025 (-70.4% vs Mar 2025, -38.5% vs Sept 2024)
- Net Profit of ₹-76 Cr in Sept 2025 (-26.7% vs Mar 2025, +29.0% vs Sept 2024)
- EBITDA of ₹-66 Cr in Sept 2025 (-24.5% vs Mar 2025)
- Operating Margin of -836.0% in Sept 2025 (-640.0pp vs Mar 2025)
- Earnings Per Share of ₹-2.34 in Sept 2025 (-27.2% vs Mar 2025)
Sun Pharma Advanced Research Co Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 8 | 27 | 19 | 13 | 21 | -70.4% | -38.5% |
| Net Profit (₹ Cr) | -76 | -60 | -52 | -107 | -106 | - | - |
| EBITDA (₹ Cr) | -66 | -53 | -43 | -103 | -101 | - | - |
| EPS (₹) | -2.34 | -1.84 | -1.60 | -3.31 | -3.26 | - | - |
| Operating Margin (%) | -836.0% | -196.0% | -540.0% | -800.0% | -639.0% | - | - |
Sun Pharma Advanced Research Co Share Price Trend Around Quarterly Results
Visualize Sun Pharma Advanced Research Co's 1-year price movement across quarterly results — ideal for logging trades in Sun Pharma Advanced Research Co share price
chart using Tickjournal. All values in ₹.
Related Pages for Sun Pharma Advanced Research Co
Additional stock information and data for SPARC
Revenue Trend (₹ Cr)
Sept 2024
13
Jun 2025
19
Mar 2025
27
Sept 2025
8
Net Profit Trend (₹ Cr)
Sept 2024
-107
Jun 2025
-52
Mar 2025
-60
Sept 2025
-76
Operating Margin Trend (%)
Sept 2024
-800.0%
Jun 2025
-540.0%
Mar 2025
-196.0%
Sept 2025
-836.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Sun Pharma Advanced Research Co quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores